Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - AEOLUS PHARMACEUTICALS, INC. | Financial_Report.xls |
| EX-31.1 - EXHIBIT 31.1 - AEOLUS PHARMACEUTICALS, INC. | exh31_1.htm |
| EX-23.1 - EXHIBIT 23.1 - AEOLUS PHARMACEUTICALS, INC. | exh23_1.htm |
| EX-32.1 - EXHIBIT 32.1 - AEOLUS PHARMACEUTICALS, INC. | exh32_1.htm |
| EX-31.2 - EXHIBIT 31.2 - AEOLUS PHARMACEUTICALS, INC. | exh31_2.htm |
| EX-21.1 - EXHIBIT 21.1 - AEOLUS PHARMACEUTICALS, INC. | exh21_1.htm |
| EX-10.27 - EXHIBIT 10.27 - AEOLUS PHARMACEUTICALS, INC. | exh10_27.htm |
| 10-K - AEOLUS PHARMACEUTICALS, INC - AEOLUS PHARMACEUTICALS, INC. | aeolus10k.htm |
EXHIBIT 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements of Aeolus Pharmaceuticals, Inc. on Form S-8 (File Nos. 333-12923, 333-53017, 333-33636, 333-94169, 333-58754, 333-99421, 333-98635, 333-98637, 333-99421, 333-115499, 333-121424, 333-121425 and 333-141633), of our report dated December 28, 2010, appearing in the Annual Report on Form 10-K of Aeolus Pharmaceuticals, Inc. for the year ended September 30, 2011, which includes an explanatory paragraph expressing substantial doubt about the Company’s ability to continue as a going concern.
/s/ Haskell & White LLP
HASKELL & WHITE LLP
Irvine, California
December 21, 2011